These may include cancer types (e.g., ccRCC vs. non-ccRCC kidney cancer or bladder vs. kidney cancer), species (mouse vs. human), or experimental conditions (e.g., hypoxia, glycolysis, or dual knockdown of GPD1 and GPD1L). Here, GPD1L is linked to kidney cancer.